Functional Brands, Inc. - Common Stock (MEHA)
Healthcare › Medicinal Chemicals & Botanical Products
Price History
Feb 9, 2026 — May 11, 2026Investment Snapshot
- Trading 61% below Graham Number ($0.25) — significant margin of safety
- Piotroski F-Score 3/9 — signs of financial weakness
- Strong ROE of 49.2% with 11.5% net margin
Functional Brands, Inc. - Common Stock (MEHA) is a Healthcare company operating in Medicinal Chemicals & Botanical Products, listed on the NASDAQ , with a market capitalisation of $2 million . Key value metrics: P/E ratio 2.6, P/B ratio 1.28, Piotroski F-Score 3 out of 9 .
Value Score
Key Metrics
Financial Statements
| Metric | FY22 | FY23 | FY24 |
|---|---|---|---|
| Revenue | $X.XB | $X.XB | $X.XB |
| Gross Profit | $X.XB | $X.XB | $X.XB |
| Operating Income | $X.XB | $X.XB | $X.XB |
| Net Income | $X.XB | $X.XB | $X.XB |
| EBITDA | $X.XB | $X.XB | $X.XB |
| Total Assets | $X.XB | $X.XB | $X.XB |
| Total Liabilities | $X.XB | $X.XB | $X.XB |
Functional Brands, Inc. - Common Stock — Fundamental Analysis Summary
Functional Brands, Inc. - Common Stock (MEHA) is trading 61% below its Graham Number of $0.25 — a significant margin of safety by Benjamin Graham's standard. The stock carries a low trailing P/E ratio of 2.6x.
On financial health, MEHA shows a weak Piotroski F-Score of 3/9, a signal of deteriorating financial health, and strong return on equity of 49.2% (sector average: -20.6%), and minimal leverage with a debt-to-equity ratio of 0.19.
StockPik's composite Value Score for MEHA is 100/100 — placing it in undervalued territory. The score is built from ten fundamental signals: P/E, P/B, PEG ratio, P/S ratio, return on equity, gross margin, debt-to-equity, current ratio, dividend yield, and Piotroski F-Score.
MEHA reports a solid gross margin of 52.7% (sector average: 40.1%) and a negative operating margin of -21.2%.
MEHA shows revenue growing at 1% year-over-year, with earnings growing at 236%.